Gemini Therapeutics, Inc.

NasdaqGM:GMTX Rapporto sulle azioni

Cap. di mercato: US$58.5m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Gemini Therapeutics Gestione

Gestione criteri di controllo 1/4

Informazioni chiave

Georges Gemayel

Amministratore delegato

US$717.4k

Compenso totale

Percentuale dello stipendio del CEO5.3%
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del management1.2yrs
Durata media del Consiglio di amministrazione2.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Georges Gemayel rispetto agli utili di Gemini Therapeutics?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2022n/an/a

-US$43m

Jun 30 2022n/an/a

-US$59m

Mar 31 2022n/an/a

-US$68m

Dec 31 2021US$717kUS$38k

-US$72m

Compensazione vs Mercato: Georges's total compensation ($USD717.44K) is about average for companies of similar size in the US market ($USD749.99K).

Compensazione vs guadagni: Insufficient data to compare Georges's compensation with company performance.


AMMINISTRATORE DELEGATO

Georges Gemayel (62 yo)

less than a year

Mandato

US$717,436

Compensazione

Dr. Georges Gemayel, Ph D.,CFA, serves as Director of GlycoEra AG since July 2022. He has been Executive Chairperson of Gemini Therapeutics, Inc. since November 2021 and has been its Interim President and...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Georges Gemayel
Interim President & CEO and Executive Chairpersonless than a yearUS$717.44kNessun dato
Brian Piekos
Chief Business Officer1.8yrsUS$4.17m0%
$ 0
Jason Meyenburg
Advisorno dataUS$10.36m0%
$ 0
Patrick Truesdell
VP of Finance & Controller1.2yrsNessun datoNessun dato

1.2yrs

Durata media

45yo

Età media

Gestione esperta: GMTX's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Georges Gemayel
Interim President & CEO and Executive Chairperson1.6yrsUS$717.44kNessun dato
Carl Gordon
Independent Director6.7yrsUS$78.55k0.040%
$ 23.3k
David Lubner
Independent Director2.7yrsUS$749.99k0%
$ 0
Jason Rhodes
Independent Director6.7yrsUS$74.67k0.040%
$ 23.3k
John Atkinson
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Napoleone Ferrara
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Tuyen Ong
Independent Director2.3yrsUS$750.00k0%
$ 0
Aravind Asokan
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Dean Bok
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Michael Ehrmann
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Shannon Boye
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Catherine Rickman
Member of Scientific Advisory Boardno dataNessun datoNessun dato

2.7yrs

Durata media

57.5yo

Età media

Consiglio di amministrazione esperto: GMTX's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.